-heparin, a mast cell product, could inhibit Proteoglycans are a family of structurally anaphylaxis 7 and more recently it has been distinct, polyanionic complex carbo-shown by some, 8 but not all, 9 investigators to hydrates composed of repeating di-inhibit mast cell mediated bronchoconstriction saccharide units. Proteoglycans include and skin responses. It is also now apparent heparin, heparan sulphate, chondroitin 4-from several studies that heparin can inhibit sulphate, chondroitin 6-sulphate, derma-allergen induced eosinophil infiltration into the tan sulphate, and hyaluronic acid. Heparin airways of experimental animals following is found in the granules of a subset of mast intravenous administration or inhalation.
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cells where it is bound to various mediators Furthermore, in allergic rabbits and sheep hepincluding histamine. Heparan sulphate arin can attenuate allergen induced airways has a much wider distribution in the body, hyperresponsiveness. 1 being associated with stromal matrices, For inflammatory cells to enter tissue such basement membrane and many cell sur-as the lung it is now recognised that there are faces, particularly the surface of endo-a number of stages involved including: (1) thelial cells. Heparin is an anticoagulant, adhesion to the vascular endothelium, (2) dibut it is now very apparent that it possesses apedesis across the endothelial cells, and (3) many other biological activities that have chemotaxis within tissues. It is clear that relevance to our understanding of lung heparin can inhibit all the stages of cell diseases, particularly inflammatory dis-migration including the carbohydrate-selectin eases of the airway. Recent evidence sug-interactions between endothelial cells and gests that heparin may have beneficial leucocytes, the presentation of specific chemoeffects in the airway when administered attractants to activated leucocytes, and leucoby inhalation that could be exploited cyte trafficking.
1 Whilst mechanisms therapeutically.
underlying the effect of heparin on neutrophil (Thorax 1997; 52:924-925) migration are well understood, 1 the ability of heparin to interfere with eosinophil adherence Keywords: heparin, proteoglycans, cell adhesion, airway and diapedesis is less well understood. Noneremodelling, asthma, airways inflammation. theless, heparin is able to inhibit the actions of several important eosinophil chemoattractants such as platelet factor 4 (PF-4) and regulated There is now increasing evidence that the nat-upon activation, normal T expressed and seurally occurring glycosaminoglycan, heparin, creted (RANTES). 1 has a wide range of biological properties that One of the consequences of activated eoscan be considered beneficial in the context of inophils in the airways is damage to the resregulation of the inflammatory response.
piratory epithelial cell layer. Eosinophil derived Heparin can inhibit the influx of neutrophils substances such as major basic protein and into certain tissues and inhibit T cell trafficking, eosinophil peroxidase are known to be capable partly by an inhibitory effect on the heparinase of eliciting ciliastasis and frank epithelial damenzyme secreted by T cells as part of the age.
1 It is of interest therefore that heparin has mechanisms whereby these cells travel across been shown to inhibit such cytotoxic activity the vascular endothelium.
1 Heparin has been in vitro 1 and to protect against changes in the reported to inhibit delayed hypersensitivity airway following exposure to cationic proteins. stick", Teflon-like surface to limit the extent of Hopefully such research will ultimately lead to a new class of drug for the treatment of chronic the cellular adhesion and diapedesis. Furinflammatory disease of the lung. thermore, the release of heparin provides a plausible homeostatic mechanism to limit tis- Furthermore, topical heparin has been shown
